All In Biotech

Drug Trial Radar · NCT03747458

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase

Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

40

Actual

Start

Dec 31, 2018

Primary completion

Mar 31, 2026

Study completion Jun 11, 2026

Sponsor

Lead sponsor
Optinose US Inc.Industry
Sponsor type
Industry
Collaborators
Paratek Pharmaceuticals Inc
First posted
Nov 20, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 16-Week Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps followed by a 12-Week Open-Label Treatment Phase. The total planned number of subjects is approximately 72 adolescents (12-17 years of age) who will be randomly assigned to receive 1 of 2 study treatments using a 2:1 ratio (OPN-375 186 μg: Placebo). For the PK sub-study, up to 14 subjects will be enrolled to obtain 10 completers.

Conditions

  • Bilateral Nasal Polyposis

Interventions

  • OPN-375Drug

    OPN-375, BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in nasal congestion/obstruction symptoms (mild, moderate, severe) at the end of Week 4Time frame: 4 Weeks
  2. Mean change from baseline at Week 16 in total polyp gradeTime frame: 16 Weeks

Locations

31 sites in 2 countries. Site status is shown where the registry gives one.

  • San Tan Allergy & Asthma

    Gilbert, Arizona

  • Kern Research

    Bakersfield, California

  • Central California Clinical Research

    Fresno, California

  • Sensa Health

    Los Angeles, California

  • Children's Hospital of Los Angeles

    Los Angeles, California

  • Children's Hospital of Orange County

    Orange, California

  • Allergy and Asthma Consultants

    Redwood City, California

  • Sacramento ENT

    Roseville, California

  • Rady Children's Hospital San Diego

    San Diego, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Children's Healthcare of Atlanta

    Atlanta, Georgia

  • Chicago ENT

    Chicago, Illinois

  • Kentuckiana ENT

    Louisville, Kentucky

  • University of Rochester

    Rochester, New York

  • Allergy Asthma & Immunology Research Institute

    Charlotte, North Carolina

  • Allergy, Asthma & Clinical Research Center

    Oklahoma City, Oklahoma

  • Vital Prospects Clinical Research Institute, P.C.

    Tulsa, Oklahoma

  • Carolina ENT

    Orangeburg, South Carolina

  • STAAMP Research

    San Antonio, Texas

  • University of Utah

    Salt Lake City, Utah

  • Eastern Virginia Medical School - Otolaryngology

    Norfolk, Virginia

  • Spokane ENT

    Spokane Valley, Washington

  • Sanatorio Guemes

    Buenos Aires, Argentina

  • Fundacion CIDEA

    Buenos Aires, Argentina

  • InAER - Investigaciones en Alergia y Enfermedades Respiratorias

    Buenos Aires, Argentina

  • Instituto de Asma Alergia y Enfermedades Respiratoria (IAAER)

    Corrientes, Argentina

  • Centro Medico INSARES

    Mendoza, Argentina

  • Instituto Medico Rio Cuarto

    Río Cuarto, Córdoba Province, Argentina

  • Instituto Medico de la Fundacion de Estudios Clinicos - Consultorios Integrados Rosario

    Rosario, Santa Fe Province, Argentina

  • Centro de Investigaciones Clinicas - Instituto de la Salud Rosario

    Rosario, Santa Fe Province, Argentina

  • Clinica Mayo, UMCB

    San Miguel de Tucumán, Tucumán Province, Argentina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.